Treating obesity using glucagon-like peptide-1-directed N-methyl-D-aspartate receptor inhibition Post author: Post published:May 20, 2024 Post category:uncategorized Bimodal drug that successfully cures obesity, hyperglycemia, and dyslipidemia in mouse models. You Might Also Like Advancing living materials with precise control over mechanical properties February 6, 2025 CAR T-cell therapy for multiple myeloma shows no difference in survival outcomes by race and ethnicity October 19, 2023 Bidirectional movement drives DNA loop formation January 16, 2025
CAR T-cell therapy for multiple myeloma shows no difference in survival outcomes by race and ethnicity October 19, 2023